Document Detail


Characterization of a uricase from Bacillus fastidious A.T.C.C. 26904 and its application to serum uric acid assay by a patented kinetic uricase method.
MedLine Citation:
PMID:  16689679     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An intracellular uricase from Bacillus fastidious A.T.C.C. 26904 was characterized and evaluated for serum uric acid assay by a patented kinetic uricase method. The active uricase was 151 kDa by gel filtration through Sephadex G-200. Both SDS/PAGE and matrix-assisted laser-desorption ionization-time-of-flight MS resolved a single polypeptide with a molecular mass of approx. 36.0 kDa. The N-terminal sequence was AERTMFYGKGDV. The optimum pH for this uricase ranged from 9.0 to 10.5. At pH 9.2, the Km (Michaelis-Menten constant) was 204+/-14 micromol/l (n=8) and the Ki (inhibition constant) for xanthine was 41+/-7 micromol/l (n=5). By analysing the data monitored within 5 min at 0.03 unit/ml uricase, this kinetic uricase method gave linear response to uric acid in reaction solution from 1.3 to 60 micromol/l. Aside from other common errors, 30 micromol/l xanthine in the reaction solution caused no error in this kinetic uricase method, while it caused negative error in the indirect equilibrium method by peroxidase-coupled assay of H2O2. Uric acid in clinical sera by this kinetic uricase method (Ck) closely and positively correlated with that from the indirect equilibrium method (Ce) (Ck = 0.008+1.081 x Ce, r>0.990, n=99). However, Bland-Altman analysis suggested inconsistency between Ck and Ce. These results indicated that this kinetic uricase method using this uricase was reliable for serum uric acid assay with enhanced resistance to xanthine besides other common errors.
Authors:
Yunsheng Zhao; Lina Zhao; Gengqing Yang; Jia Tao; Youquan Bu; Fei Liao
Related Documents :
15781669 - Serum uric acid and target organ damage in primary hypertension.
16100229 - Expression of allene oxide cyclase and accumulation of jasmonates during organogenic no...
11152909 - Etiology of third-trimester maternal hyperuricemia in nonpreeclamptic twin gestations.
11473659 - Biochemical profile of idiopathic uric acid nephrolithiasis.
19299029 - Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-se...
8107949 - Influence of the renin-angiotensin system and atrial natriuretic peptide on renal funct...
11321679 - The catalytic efficiency of soybean lipoxygenase-1 is enhanced at low gravity.
18331769 - Protection of ash (fraxinus excelsior) trees from ozone injury by ethylenediurea (edu):...
16869829 - Characterization of a sialic acid- and p-selectin glycoprotein ligand-1-independent adh...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biotechnology and applied biochemistry     Volume:  45     ISSN:  0885-4513     ISO Abbreviation:  Biotechnol. Appl. Biochem.     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-11     Completed Date:  2006-11-21     Revised Date:  2007-03-21    
Medline Journal Info:
Nlm Unique ID:  8609465     Medline TA:  Biotechnol Appl Biochem     Country:  England    
Other Details:
Languages:  eng     Pagination:  75-80     Citation Subset:  IM    
Affiliation:
Laboratory of Bioinformatics and Molecular Engineering, Chongqing University of Medical Sciences, Chongqing 400016, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Bacillus / enzymology*
Bacterial Proteins / isolation & purification*
Chromatography, Gel
Hydrogen-Ion Concentration
Kinetics
Peptides / isolation & purification*
Serum
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Urate Oxidase / isolation & purification*
Uric Acid / blood*
Chemical
Reg. No./Substance:
0/Bacterial Proteins; 0/Peptides; 69-93-2/Uric Acid; EC 1.7.3.3/Urate Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mass-related traumatic tissue displacement and behavior: a screen for treatments that reduce [correc...
Next Document:  Current status of pancreatic islet transplantation.